content

Kindred Bio Expands of Manufacturing Agreement with Vaxart for COVID-19 Vaccine

Kindred Biosciences, Inc., a biopharmaceutical company developing novel biologics, announced it has expanded an agreement with Vaxart, Inc. for the manufacture of Vaxartโ€™s oral...

Astellas and Seagen Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Trial

Astellas Pharma Inc. and Seagen Inc. announced positive topline results from the second cohort of patients in the pivotal phase 2 single-arm clinical trial...

Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA

Merck, a leading science and technology company,ย  announced that it has signed agreements licensing its CRISPR technology to two companies โ€” PanCELLa, a cell...

Merck’s New VirusExpress Platform Speeds Development of Cell and Gene Therapies

Merck, a leading science and technology company, has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpressโ„ข Lentiviral Production Platform. This...

Dnata becomes first to offer fully integrated, temperature-controlled cool chain for pharma cargo in Singapore

dnata, one of the worldโ€™s leading air services providers, has further enhanced its pharma handling capabilities in Singapore by launching cool dollies in its...

Direct Biologics Granted Expanded Access by FDA for ExoFlo in the Treatment of COVID-19

Direct Biologics, LLC, announced that the FDA has granted expanded access for ExoFlo in the treatment of patients with COVID-19 associated acute respiratory distress...

Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

AstraZenecaโ€™s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read